Page last updated: 2024-09-03

ae0047 and Cerebrovascular Disorders

ae0047 has been researched along with Cerebrovascular Disorders in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kagitani, Y; Kawamura, T; Nagai, H; Narita, Y; Shinyama, H; Uchida, T; Watanabe, M1
Kagitani, Y; Kawamura, T; Nagai, H; Nakamura, N; Narita, Y; Shinyama, H1
Kido, H; Kubo, Y; Nakamura, N; Nakayama, T; Nishikawa, M1

Other Studies

3 other study(ies) available for ae0047 and Cerebrovascular Disorders

ArticleYear
Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2

    Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Hemodynamics; Hypertension; Male; Rats; Rats, Inbred SHR

1995
Therapeutic effects of AE0047, a novel calcium antagonist, on progression of brain damage after stroke in stroke-prone spontaneously hypertensive rats.
    General pharmacology, 1998, Volume: 30, Issue:3

    Topics: Animals; Brain; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Hydralazine; Male; Nicardipine; Rats; Rats, Inbred SHR; Vasodilator Agents

1998
Protection against endothelial abnormalities by a novel calcium channel blocker, AE0047, in stroke-prone spontaneously hypertensive rats.
    General pharmacology, 1999, Volume: 32, Issue:3

    Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Calcium Channel Blockers; Cerebrovascular Disorders; Dihydropyridines; Endothelium, Vascular; Heart Rate; Hypertension; Male; Prostaglandins; Protective Agents; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstriction; Vasodilation

1999